Regenerative Medicine Market

The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%. The global market is broadly classified into types, therapy, application and regions. Based on types, the market is segmented into cell-based products and acellular products. The cell-based products is expected to dominate the global market in 2018.Based on therapy, the market is segmented into cell therapygene therapytissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market, during the forecast period. This market is also segmented by application. By application, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications.

    Related Conference of Regenerative Medicine Market

    March 15-15, 2021

    Genetics and Molecular biology

    Paris, France
    September 27-28, 2021

    15th International Conference on Genomics & Pharmacogenomics

    Vancouver, Canada
    October 18-19, 2021

    20th International Conference on Structural Biology

    Rome, Italy
    December 07-08, 2021

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 09-10, 2021

    2nd International Conference on Geriatrics and Ageing

    Sydney, Australia

    Regenerative Medicine Market Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in